Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bioanalytical Strategies for Advanced Therapies | Contract Pharma
Ebook

Bioanalytical Strategies for Advanced Therapies

As the cell and gene therapy market continues to grow, analytical science will play an increasingly important role.

Released By Catalent

Analytical Science: Evolving and Adapting for Advanced Medicines
In the last 10 to 15 years, the pharmaceutical industry has made significant strides in leveraging the full potential of cell and gene therapies, as several products have successfully made it through clinical development to approval.
Read More >>

Analytical Considerations in the Lifecycle Management of Biologics
Biologics represent a growing sector of the pharmaceutical industry. They are medicinal products derived from various natural sources and extracted or produced by genetic engineering techniques or other technologies.
Read More >>

The Design of Experiments Approach to Analytical Method Development
The European Medicines Agency (EMA) defines the quality by design (QbD) approach as one that aims to ensure the quality of medicines by employing statistical, analytical, and risk-management methodology in the design, development and manufacturing of medicines.
Read More >>

Leveraging Novel Analytical Approaches for Advanced Therapies
Small molecule-based drugs were the primary choice of physicians for the treatment or prevention of disease, until monoclonal antibodies were added to their arsenal with the first approval in 1986
Read More >>


Request more information from Catalent

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters